Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ProPhase Labs (PRPH) Other Operating Expenses: 2010-2024

Historic Other Operating Expenses for ProPhase Labs (PRPH) over the last 13 years, with Dec 2024 value amounting to -$6,000.

  • ProPhase Labs' Other Operating Expenses was N/A to -$6,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $1.9 million, marking a year-over-year change of. This contributed to the annual value of -$6,000 for FY2024, which is 100.31% down from last year.
  • ProPhase Labs' Other Operating Expenses amounted to -$6,000 in Q4 2024, which was down 104.55% from $132,000 recorded in Q3 2023.
  • Over the past 5 years, ProPhase Labs' Other Operating Expenses peaked at $10.6 million during Q4 2021, and registered a low of -$4.0 million during Q3 2021.
  • For the 3-year period, ProPhase Labs' Other Operating Expenses averaged around $1.7 million, with its median value being $1.5 million (2022).
  • Per our database at Business Quant, ProPhase Labs' Other Operating Expenses crashed by 1,052.27% in 2020 and then skyrocketed by 942.40% in 2021.
  • Quarterly analysis of 5 years shows ProPhase Labs' Other Operating Expenses stood at -$1.3 million in 2020, then soared by 942.40% to $10.6 million in 2021, then plummeted by 70.68% to $3.1 million in 2022, then crashed by 94.50% to $132,000 in 2023, then reached -$6,000 in 2024.
  • Its Other Operating Expenses was -$6,000 in Q4 2024, compared to $132,000 in Q3 2023 and $597,000 in Q2 2023.